Search for: "Schering Corp" Results 161 - 180 of 251
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
16 Oct 2009, 3:18 pm
Dietary supplement claims must be substantiated by scientific evidence, the FDA has guidance for industry about this. [read post]
1 Oct 2009, 2:14 am
Apotex Corp., 2008 WL 2047979 (S.D. [read post]
27 Sep 2009, 12:38 am
Merck, which is set to buy rival Schering-Plough Corp. by the end of the year, won 11 of 16 Vioxx suits at trial before agreeing to settle all claims. [read post]
26 Aug 2009, 5:14 pm
"); Bayer Schering Pharma AG v. [read post]
16 Aug 2009, 9:51 pm
In arguing their motion, Microsoft unfortunately relied on Schering Corp v Pfizer (1999) where, although the Court had excluded five surveys from evidence under the hearsay rule, the Court did not discuss Rule 703 save to say, damagingly for Microsoft, that it was an acceptable basis to admit survey evidence. [read post]
16 Aug 2009, 9:21 pm
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
13 Aug 2009, 9:19 am
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
11 Aug 2009, 3:23 am
Neutrogena Corp., --- F.Supp.2d ----, 2009 WL 2407207 (D.Del.) [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing  Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
23 Jul 2009, 3:15 am
We wouldn't base a motion solely on Actimmune, but with Pennsylvania Employees as the lead case, Actimmune is useful supporting precedent.Another candidate for best supporting actor in this area is In re Schering-Plough Corp. [read post]
22 Jul 2009, 12:32 pm
Louis drug liability lawyer, I was scandalized but not surprised by a recent revelation that Merck & Co. and Schering-Plough Corp. actively suppressed evidence about their drugs' efficacy in order to prtect their bottom lines. [read post]
13 Jul 2009, 9:28 pm
A tip of the old cyberhat - and not for the first time - to Alan Modlinger at Lowenstein Sandler for passing along to us the latest good news on the off-label promotion front - dismissal (with leave to replead under Twombly) in In re Schering-Plough Corp. [read post]